Valuation Workshop at RESI Conference – Boston, September 2017

During the last RESI (Redefining Early Stage Investments) Conference – the event series organized by Life Science Nation, a Venture Valuation long-time partner – Dr. Patrik Fried delivered a session on life science deal and product valuations. The notes from the workshop are available to download here

Read more

Assessing the Valuation of New Ventures – MassChallengeCH, Lausanne, September 2017

Venture Valuation CEO, Dr. Patrik Frei is one of the experts working as mentors for MassChallengeCH, a famous startup accelerator. He helps new entrepreneurs understand the concepts and meaning of company valuation. Below, you can find a link to the notes from his workshop about assessing a company prior to valuation. Assessing the Valuation of New … Continue reading Assessing the Valuation of New Ventures – MassChallengeCH, Lausanne, September 2017

Read more

Dr. Patrik Frei Delivers a Webinar to Harvard Business School Alumni

On 7th of June 2017, CEO of Venture Valuation, Dr Patrik Frei, delivered a live webinar titled ‘Valuation of Life Sciences Start-up’ to healthcare alumni of Harvard Business School. The online event was a part of Healthcare Roundtable, a series of interactive presentations by industry leaders organised by HBS Healthcare Alumni Association. Dr. Frei talked about the significance … Continue reading Dr. Patrik Frei Delivers a Webinar to Harvard Business School Alumni

Read more

Life Sciences Clusters in Europe

What makes a European Life Science site attractive to foreign investors? Together with KPMG Switzerland Venture Valuation has published this second edition statistic and extensive numbers on the European Biotechnology, Medical Technology and Pharma environment. The data is based on Biotechgate, the global Life Sciences database. Site Selection for Life Sciences Companies in Europe 2015: … Continue reading Life Sciences Clusters in Europe

Read more